{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:43:03Z","timestamp":1769442183635,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejso.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T02:04:00Z","timestamp":1684548240000},"page":"106939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of induction therapy in locally advanced intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"49","author":[{"given":"Alix","family":"Dhote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-0320","authenticated-orcid":false,"given":"Stylianos","family":"Tzedakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hobeika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-8340","authenticated-orcid":false,"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-3456","authenticated-orcid":false,"given":"Alexandra","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Beaufr\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Codjia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Goumard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Scatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Dohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-3939","authenticated-orcid":false,"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Terris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2397-4599","authenticated-orcid":false,"given":"Mickael","family":"Lesurtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safi","family":"Dokmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fuks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2023.05.014_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ejso.2023.05.014_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2023.05.014_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/SLA.0b013e318236c21d","article-title":"Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group","volume":"254","author":"Farges","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.05.014_bib5","series-title":"Survival rates for bile duct cancer","year":"2020"},{"key":"10.1016\/j.ejso.2023.05.014_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2023.05.014_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/bjs.10641","article-title":"Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"105","author":"Le Roy","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2023.05.014_bib8","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1245\/s10434-020-08486-7","article-title":"Downstaging with radioembolization or chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"27","author":"Riby","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib9","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1245\/s10434-014-4365-3","article-title":"Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment","volume":"22","author":"Rayar","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/RLU.0000000000000904","article-title":"Glass microspheres 90Y selective internal radiation therapy and chemotherapy as first-line treatment of intrahepatic cholangiocarcinoma","volume":"40","author":"Edeline","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejso.2023.05.014_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-015-4768-9","article-title":"Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery","volume":"22","author":"Kato","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4254\/wjh.v12.i10.693","article-title":"Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma","volume":"12","author":"Akateh","year":"2020","journal-title":"WJH"},{"key":"10.1016\/j.ejso.2023.05.014_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","article-title":"Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Edeline","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2023.05.014_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.05.014_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2023.05.014_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","article-title":"Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery","volume":"149","author":"Koch","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2023.05.014_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","article-title":"Post-hepatectomy haemorrhage: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"13","author":"Rahbari","year":"2011","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2023.05.014_bib20","first-page":"658","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.ejso.2023.05.014_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2023.05.014_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00259-015-3210-7","article-title":"Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis","volume":"43","author":"Edeline","year":"2016","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejso.2023.05.014_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00259-018-4199-5","article-title":"Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience","volume":"46","author":"Bourien","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejso.2023.05.014_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000449341","article-title":"Selective internal radiation therapy (SIRT) as conversion therapy for unresectable primary liver malignancies","volume":"5","author":"Cucchetti","year":"2016","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejso.2023.05.014_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2023.05.014_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12885-020-07097-5","article-title":"Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma","volume":"20","author":"Ling","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2023.05.014_bib30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1245\/s10434-020-09390-w","article-title":"Tumor necrosis impacts prognosis of patients undergoing curative-intent hepatocellular carcinoma","volume":"28","author":"Wei","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1245\/s10434-016-5472-0","article-title":"Prognostic significance of tumor necrosis in hilar cholangiocarcinoma","volume":"24","author":"Atanasov","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.014_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1331806","article-title":"Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma","volume":"6","author":"Atanasov","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejso.2023.05.014_bib33","unstructured":"Tsilimigras, D. I. Tumor necrosis impacts prognosis of patients undergoing resection for T1 intrahepatic cholangiocarcinoma."},{"key":"10.1016\/j.ejso.2023.05.014_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.surg.2019.12.009","article-title":"Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: a nationwide survey of the Liver Cancer Study Group of Japan","volume":"167","author":"Watanabe","year":"2020","journal-title":"Surgery"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:50:28Z","timestamp":1760061028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323005085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0748798323005085"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.05.014","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of induction therapy in locally advanced intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106939"}}